Product Images Esomeprazole Magnesium

The text describes the results of a study evaluating the efficacy of two doses of Esomeprazole (40 mg and 20 mg) compared to a placebo in treating patient symptoms. The data is presented in a table showing the percent of patients who were symptom-free after 14, 21, and 28 days. The table suggests that both doses of Esomeprazole led to higher percentages of symptom-free patients compared to the placebo. However, without more information about the symptoms being treated, the study design, and sample size, it is difficult to draw any further conclusions.*

The text is not available because it lacks context and meaning.*

The text describes a medication in the form of delayed-release capsules containing esomeprazole magnesium, USP. The capsule strength is 22.25 mg and equivalent to 20 mg of esomeprazole. The usual dosage instructions are not provided in the text. The medication should be kept out of reach of children and stored at room temperature between 20° to 26°C. It is manufactured for Mylan Pharmaceuticals Inc, located in Morgantown, WY, USA. The medication is dispensed in a container with a child-resistant closure. The text also contains various code numbers and prompt instructions related to variable data online coding that can be used for printing purposes.*

This is a prescription drug containing 40 mg of Esomeprazole magnesium in each delayed-release capsule. The medication guide should be provided to each patient. The usual dosage information is in the prescribing information. It should be stored between 20°C to 26°C (68°F to 77°F) in a tightly closed container out of the reach of children. It is manufactured for Mylan Pharmaceuticals Inc. and made in India. The product information contains a National Drug Code (NDC) 0378-2351-93 and a code number MHDRUGS/25/NKD/82. The LOT number is 1234567, and the expired date is shown as MMM.YYYY. The text also provides some additional information about dispensing and storage.*